Parallel Advisors, LLC Boston Scientific Corp Transaction History

Parallel Advisors, LLC

$4.31 Billion
Q1 2025

A detailed history of Parallel Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 15,459 shares of BSX stock, worth $1.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,459

Previous 14,711 5.08%

Holding current value

$1.59 Million

Previous $1.31 Million 18.74%

% of portfolio

0.04%

Previous 0.03%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	BUY	$89.38 - $106.18 $66,856 - $79,422	748 Added 5.08%	15,459 $1.56 Million
Q4 2024 Feb 10, 2025	BUY	$83.62 - $91.5 $121,499 - $132,949	1,453 Added 10.96%	14,711 $1.31 Million
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $107,105 - $123,312	1,468 Added 12.45%	13,258 $1.11 Million
Q2 2024 Aug 08, 2024	BUY	$67.33 - $77.71 $105,169 - $121,383	1,562 Added 15.27%	11,790 $907,000
Q1 2024 May 06, 2024	BUY	$57.6 - $68.62 $29,894 - $35,613	519 Added 5.35%	10,228 $700,000
Q4 2023 Feb 09, 2024	SELL	$48.64 - $57.81 $16,294 - $19,366	-335 Reduced 3.34%	9,709 $561,000
Q3 2023 May 20, 2024	BUY	$50.19 - $54.68 $22,183 - $24,168	442 Added 4.6%	10,044 $530,000
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $22,183 - $24,168	442 Added 4.6%	10,044 $530,000
Q2 2023 May 20, 2024	BUY	$49.72 - $54.64 $22,672 - $24,915	456 Added 4.99%	9,602 $519,000
Q2 2023 Aug 04, 2023	BUY	$49.72 - $54.64 $22,672 - $24,915	456 Added 4.99%	9,602 $519,000
Q1 2023 May 20, 2024	SELL	$45.09 - $50.03 $48,787 - $54,132	-1,082 Reduced 10.58%	9,146 $457,000
Q1 2023 Apr 25, 2023	BUY	$45.09 - $50.03 $61,683 - $68,441	1,368 Added 17.59%	9,146 $457,000
Q4 2022 Feb 03, 2023	BUY	$39.56 - $47.22 $5,221 - $6,233	132 Added 1.73%	7,778 $359,000
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $53,119 - $158,678	1,447 Added 23.34%	7,646 $296,000
Q2 2022 Aug 01, 2022	SELL	$35.24 - $47.1 $53,917 - $72,063	-1,530 Reduced 19.8%	6,199 $231,000
Q1 2022 Apr 28, 2022	BUY	$40.9 - $45.1 $42,045 - $46,362	1,028 Added 15.34%	7,729 $345,000
Q4 2021 Jan 20, 2022	SELL	$38.07 - $44.87 $31,141 - $36,703	-818 Reduced 10.88%	6,701 $285,000
Q3 2021 Nov 02, 2021	BUY	$41.23 - $45.88 $73,100 - $81,345	1,773 Added 30.86%	7,519 $326,000
Q2 2021 Aug 06, 2021	BUY	$38.58 - $44.24 $53,278 - $61,095	1,381 Added 31.64%	5,746 $246,000
Q1 2021 Apr 23, 2021	BUY	$35.27 - $39.67 $25,500 - $28,681	723 Added 19.85%	4,365 $169,000
Q4 2020 Feb 02, 2021	SELL	$33.15 - $41.97 $48,365 - $61,234	-1,459 Reduced 28.6%	3,642 $131,000
Q3 2020 Oct 27, 2020	SELL	$34.44 - $42.23 $3,857 - $4,729	-112 Reduced 2.15%	5,101 $195,000
Q2 2020 Jul 16, 2020	BUY	$30.19 - $39.11 $90 - $117	3 Added 0.06%	5,213 $183,000
Q1 2020 Apr 27, 2020	SELL	$25.83 - $45.71 $5,734 - $10,147	-222 Reduced 4.09%	5,210 $170,000
Q4 2019 Jan 30, 2020	BUY	$37.87 - $45.37 $53,283 - $63,835	1,407 Added 34.96%	5,432 $246,000
Q3 2019 Nov 01, 2019	BUY	$40.31 - $43.45 $29,023 - $31,284	720 Added 21.79%	4,025 $164,000
Q2 2019 Aug 05, 2019	SELL	$34.91 - $42.98 $5,096 - $6,275	-146 Reduced 4.23%	3,305 $142,000
Q1 2019 May 01, 2019	BUY	$32.91 - $40.75 $4,640 - $5,745	141 Added 4.26%	3,451 $132,000
Q4 2018 Feb 05, 2019	BUY	$31.73 - $39.04 $16,753 - $20,613	528 Added 18.98%	3,310 $116,000
Q3 2018 Nov 01, 2018	BUY	$32.83 - $38.63 $9,520 - $11,202	290 Added 11.64%	2,782 $107,000
Q1 2018 May 08, 2018	BUY	$25.2 - $28.54 $151 - $171	6 Added 0.24%	2,492 $68,000
Q4 2017 Feb 13, 2018	SELL	$24.79 - $29.8 $3,123 - $3,754	-126 Reduced 4.82%	2,486 $62,000
Q3 2017 Nov 15, 2017	BUY	$26.26 - $29.17 $68,591 - $76,192	2,612 New	2,612 $74,000
Q3 2017 Nov 14, 2017	SELL	$26.26 - $29.17 $67,514 - $74,996	-2,571 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	2,571	2,571 $68,000

Others Institutions Holding BSX

# of Institutions

1,831

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Boston Scientific Corp Transaction History